Specialty vaccine company Valneva, along with Pfizer, reported positive Phase II data from their clinical trial evaluating a Lyme disease vaccine candidate.
BioSpace reviewed some of the more interesting scientific studies recently published, including research into a potential cause of Alzheimer’s disease and how deleting dysfunctional fat cells could alleviate diabetes.
While most of us are concerned about Lyme disease, a tickborne illness circulating during the spring and summertime in the Northeastern U.S, there is another, potentially more serious infection to be aware of as well. The causative organism behind Lyme disease, the spirochete Borriela burgdorferi, is not alone. An emerging tickborne infection in the Northeastern […]